Comparison Chart Seikagaku Corporation

Equities

Delayed Japan Exchange Other stock markets 08:54:02 2024-05-15 pm EDT			5-day change	1st Jan Change
769 ^JPY	-0.90%		+3.78%	+0.92%

Apr. 08	Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	CI
2023	Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	SEIKAGAKU CORPORATION	Other Pharmaceuticals	-0.90%	+3.78%	+0.92%	-2.41%	-34.58%	273M